Immune to Cancer: The CRI Blog
-
CICON16: The Future of Cancer Immunotherapy
CICON16 ended by focusing on emerging treatments and technologies in cancer immunotherapy.
-
CICON16: The Power of Combinations
Targeting tumors from multiple angles improves our odds of success.
-
CICON16: Bacteria and Cancer Immunity
New research shows that bacteria within us can influence both the development of cancer and the immune…
-
CICON16: Corrupted by Cancer
Day 2 of CICON16 explored strategies to overcome challenges within the tumor microenvironment.
-
CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints
The latest advances in using new checkpoint drugs to target LAG-3, Nrp1, IL-35R, CD36, and mitochondrial metabolism.
-
CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches
Antigens are the key to effective vaccines and the immune system’s ability to target cancer cells.
-
CICON16: Translating Science Into Survival
This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New…
-
CICON15 Report from Day 4
Highlights from the final day of the inaugural International Cancer Immunotherapy Conference.
-
CICON15 Report from Day 3
Highlights from Day 3 of the inaugural International Cancer Immunotherapy Conference.